Neurogenesis is a well-characterized phenomenon within the dentate gyrus (DG) of the adult hippocampus. Environmental enrichment (EE) in rodents increases neurogenesis, enhances cognition, and promotes recovery from injury. However, little is known about the effects of EE on glia (astrocytes and microglia). Given their importance in neural repair, we predicted that EE would modulate glial phenotype and/or function within the hippocampus. Adult male rats were housed either 12 h/day in an enriched environment or in a standard home cage. Rats were injected with BrdU at 1 week, and after 7 weeks, half of the rats from each housing group were injected with lipopolysaccharide (LPS), and cytokine and chemokine expression was assessed within the periphery, hippocampus and cortex. Enriched rats had a markedly blunted pro-inflammatory response to LPS within the hippocampus. Specifically, expression of the chemokines Ccl2, Ccl3 and Cxcl2, several members of the tumor necrosis factor (TNF) family, and the pro-inflammatory cytokine IL-1b were all significantly decreased following LPS administration in EE rats compared to controls. EE did not impact the inflammatory response to LPS in the cortex. Moreover, EE significantly increased both astrocyte (GFAP+) and microglia (Iba1+) antigen expression within the DG, but not in the CA1, CA3, or cortex. Measures of neurogenesis were not impacted by EE (BrdU and DCX staining), although hippocampal BDNF mRNA was significantly increased by EE. This study demonstrates the importance of environmental factors on the function of the immune system specifically within the brain, which can have profound effects on neural function.
Introduction
Ongoing adult neurogenesis is now an accepted and wellcharacterized phenomenon within the mammalian brain, including humans, although its functions have yet to be fully elucidated. In both the subgranular zone (SGZ) of the dentate gyrus (DG) of the hippocampus and the subventricular zone of the olfactory bulb, the adult rodent brain regularly produces newly generated cells that can differentiate into neurons, astrocytes and oligodendrocytes. While these stem cells do not differentiate into microglia, it is becoming increasingly evident that microglia are critical for the development and differentiation of neural stem cells (Belmadani et al., 2006; Bhattacharyya et al., 2008; Gonzalez-Perez et al., 2010) , and that microglia interact directly with other neural cells throughout normal brain activity (Nimmerjahn et al., 2005; Tremblay and Majewska, 2011; Wake et al., 2009 ). Moreover, microglia play a key homeostatic role in neuronal survival during the first week after neurons are born in adulthood, by phagocytizing the majority of newborn cells (Sierra et al., 2010) . Nonetheless, the role of microglia in neural stem cell plasticity has been almost entirely considered in the context of pathology or disease models that alter neurogenesis (e.g., ischemia, stroke, or immunodeficiency; (for review, see Das and Basu, 2008; Horn and Schlote, 1992; Molina-Holgado and Molina-Holgado, 2010; Pulsinelli et al., 1982; Ziv et al., 2006) ). Their role within the normal brain in response to enrichment protocols that augment plasticity has not been fully explored.
Environmental enrichment (EE) is a housing manipulation that increases physical and social stimuli and has been shown to modulate plasticity within the hippocampus and other cortical regions in rodents (Baamonde et al., 2011; Di Garbo et al., 2011; Diamond et al., 1976; Sirevaag and Greenough, 1991) . These plasticity changes include increased neurogenesis and cell survival (Kempermann et al., 2002; van Praag et al., 1999) , increased gliogenesis (Ehninger and Kempermann, 2003; Steiner et al., 2004) , alterations in glial morphology and antigen expression (Viola et al., 2009; Ziv et al., 2006) , and the upregulation of growth factors including brain-derived-neurotrophic factor (BDNF), and glialderived neurotrophic factor (GDNF) (During and Cao, 2006; Ickes et al., 2000; Rossi et al., 2006; Young et al., 1999) . Notably, EE is neuroprotective following a number of insults or injuries, including seizures (Steiner et al., 2004; Young et al., 1999) , ischemia (Briones et al., 2011) 
